Table: begin end state 1 30 non-cytoplasmic 31 51 transmembrane 52 62 cytoplasmic 63 82 transmembrane 83 101 non-cytoplasmic 102 127 transmembrane 128 163 cytoplasmic 164 183 transmembrane 184 188 non-cytoplasmic 189 208 transmembrane 209 262 cytoplasmic 263 284 transmembrane 285 298 non-cytoplasmic 299 325 transmembrane 326 336 cytoplasmic 337 355 transmembrane 356 360 non-cytoplasmic 361 382 transmembrane 383 389 cytoplasmic 390 417 transmembrane 418 422 non-cytoplasmic 423 444 transmembrane 445 455 cytoplasmic
Input: >H281DRAFT_03217 FitnessBrowser__Burk376:H281DRAFT_03217 MPQSTQTRPADVTRQAGASTTASTARRSNARYQILGLLAVGTMINYLDRTVLGIAAPQLT KELGINAAMMGLLFSVFSWSYVASQIPGGLFLDRFGSKLTYFLSMTFWSLCTLAQGLVHG IAGLFVFRLGLGVSEAPCFPTNSRVVATWFPQSERAMATGTYTVGEYIGLAFFSPFLFML MGAFGWRSLFYVVGGVGIVFGVIWWLMYREPRDHPSANQAELDYIEAGGGLTHRHKDGGA AAAPAKGGFEWRTIGRLLKHRQLTGICLGQFAGNSTLVFFLTWFPTYLATERHMGWLKIG FFAIMPFIAASIGVMFGGLFSDWLLRRGKSANVARKLPIIAGLLLASTIILANYVESNVA VIAILSVAFFAQGMAALGWTLVSDIAPEGLLGVTGGIFNFAANLAGIVTPLVVGFIVAAT GSFVGALVFIGVIALIGALSYIFIVGDIKRIVLVD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server